+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asthma Spacers Market - Forecasts from 2018 to 2023

  • ID: 4756679
  • Report
  • February 2019
  • Region: Global
  • 102 pages
  • Knowledge Sourcing Intelligence LLP
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Cipla
  • Clement Clarke and
  • GlaxoSmihKline plc
  • Lupin
  • Medline
  • Monaghan
  • MORE
The asthma spacers market is projected to grow at a CAGR of 3.23% to reach US$2.395 billion by 2023, from US$1.979 billion in 2017. Growing prevalence of Asthma, chronic respiratory disease around the globe is considered as one of the key factor driving the growth of the market. According to World Health Organization nearly 235 million people suffer from asthma in the world and over 80% of the deaths occur in low and middle income countries. Increase in preference of minimally invasive procedure and technological advancement in the biotechnology and healthcare also fuels up the growth of the market. Moreover increasing healthcare awareness and rising disposable income in developing countries widens up the scope of growth for the asthma spacers market.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Asthma Spacers value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the Asthma Spacers market.

Major industry players profiled as part of the report are Pari Gmbh, GlaxoSmihKline plc, Lupin, Cipla, Clement Clarke and Medical Development International among others

Segmentation

The Asthma Spacers market has been analyzed through following segments:

By Product Type
AeroChamber
OptiChamber
Easivent
Others

By Distribution Channel
Offline
Online

By Geography
North America
USA
Canada
Mexico
Others

South America
Brazil
Argentina
Others

Europe
Germany
France
United Kingdom
Spain
Others

Middle East and Africa
United Arab Emirates
Saudi Arabia
Others

Asia Pacific
China
Japan
South Korea
India
Others
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Cipla
  • Clement Clarke and
  • GlaxoSmihKline plc
  • Lupin
  • Medline
  • Monaghan
  • MORE
1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base and Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry In the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. Asthma Spacers Market by Product Type
5.1. Aerochamber
5.2. Optichamber
5.3. Easivent
5.4. Others

6. Asthma Spacers Market by Distribution Channel
6.1. Offline
6.2. Online

7. Asthma Spacers Market by Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. United Arab Emirates
7.4.2. Saudi Arabia
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others

8. Competitive Intelligence
8.1. Competition and Offerings Analysis of Key Vendors
8.2. Recent Investment and Deals
8.3. Strategies of Key Players

9. Company Profiles
9.1. Pari Gmbh
9.2. Glaxosmihkline Plc
9.3. Lupin
9.4. Cipla
9.5. Clement Clarke
9.6. Medical Development International
9.7. Teva Pharmaceuticals
9.8. Monaghan
9.8.4. Recent Developments
9.9. Medline

List of Figures
List of Tables
Disclaimer
Note: Product cover images may vary from those shown
3 of 3
  • Pari Gmbh
  • GlaxoSmihKline plc
  • Lupin
  • Cipla
  • Clement Clarke and
  • Medical Development International
  • Teva Pharmaceuticals
  • Monaghan
  • Medline
Note: Product cover images may vary from those shown
Adroll
adroll